Open AccessReal World Experience of Pseudomonas aeruginosa Eradication at an Urban Pediatric Cystic Fibrosis Center
Author(s) -
Lindsay Jablonski,
Carlton K. K. Lee,
Beryl J. Rosenstein,
Peter J. Mogayzel,
Shruti Paranjape,
Alice Pan
Publication year - 2020
Publication title -
the journal of pediatric pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.456
H-Index - 15
eISSN - 2331-348X
pISSN - 1551-6776
DOI - 10.5863/1551-6776-25.7.623
Subject(s) - medicine , cystic fibrosis , regimen , demographics , pseudomonas aeruginosa , tobramycin , clinical practice , pediatrics , family medicine , demography , sociology , biology , bacteria , genetics
Clinical practice guidelines for eradication of Pseudomonas aeruginosa (PA) in patients with cystic fibrosis (CF) have been established , but current studies have not assessed how these guidelines translate into clinical practice. This study aimed to characterize the real-world eradication strategies, eradication rates, and microbiologic outcomes of patients with first acquisition of PA at an urban pediatric CF center.